期刊文献+

Kallistatin抗炎作用的研究进展 被引量:3

The research progress of the anti-inflammatory effect of kallistatin
下载PDF
导出
摘要 Kallistatin(KS)是一种激肽释放酶结合蛋白(kallikrein-binding protein),广泛分布于多种组织及体液中。KS不但具有抑制组织型激肽释放酶的作用,还具有抗炎、抗血管生成、抗肿瘤等多种生物学作用。KS生物学功能与其分子结构中不同的结构域有关。而KS抗炎作用被认为主要与肝素结合结构域有关。KS通过其肝素结合结构域,能竞争性抑制肿瘤坏死因子(tumor necrosis factorα,TNF-α)与它的受体的结合,从而起到影响TNF-α-NF-κB信号通路,发挥抗炎作用。K S也能与Kr uppel样因子4(Kr uppel-li ke Factor 4,KLF4)结合,激活内皮型一氧化氮合酶(endothelial nitr ic ox ide synthase,e NOS),抑制TNF-α活化核因子-κB(nuclear factor-κB,NF-κB),发挥抗炎作用。但这与肝素结合结构域的机制不同。不同的机制可能为抗炎治疗提供新的思路,本文将就Kallistatin抗炎作用的相关研究进展进行阐述。 Kallistatin(KS) is a kallikrein-binding protein,which is widely distributed in multiple tissues and body fluids.KS not only has inhibitory effect to tissue kallikrein,but also has anti-inflammatory anti-angiogenesis,anti-tumor and other biologic functions.The biologic function of KS is related to its molecular structure,which has different structural domains.The anti-inflammatory effect of KS is considered to be mainly related to the heparin-binding domain.Through this domain,KS can competitively inhibit tumor necrosis factor(TNF-α) combined with its receptors,and influence TNF-α-NF-κB signal pathway,contribute to anti-inflammatory effect.KS can also combine with Kruppellike Factor 4(KLF4),activating endothelial nitric oxide synthase(eNOS),as well as suppress TNF-α-induced nuclear factor-KB(NF-κB) activation,contribute to anti-inflammatory effect.But this mechanism is different from the mechanism of heparin-binding domain.Different mechanisms may provide a new idea for the anti-inflammatory treatment.This review focuses on the latest research progress in the anti-inflammatory effect of KS.
作者 匡枫 卿国忠
出处 《临床与病理杂志》 2016年第1期76-80,共5页 Journal of Clinical and Pathological Research
基金 湖南省科技厅资助项目(2011FJ3170)~~
关键词 Kallistain 抗炎 结构域 kallistatin anti-inflammatory structural domain
  • 相关文献

参考文献22

  • 1Chao J, Stallone JN, Liang YM, et al. Kallistatin is a potent new vasodilator[J].J Clin Invest, 1997, 100(1): 11-7.
  • 2詹丽君,卿国忠.Kallistatin的生物学作用及机制研究进展[J].临床与病理杂志,2015,35(2):319-323. 被引量:6
  • 3Hsieh JL, Shen PC, Shiau AL, et al. Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection[ J].Hum Gene er, 2009, 20(2): 147-158.
  • 4Yao Y, Li L, Huang X, et al. SERPINA3K induces apoptosis in humancolorectal cancer cells via activating the Fas/FasL/caspase-8 signaling pathway[ J]. FEBS J, 2013, 280(14): 3244-3255.
  • 5Li P, Bledsoe G, Yang ZR, et al. Human kallistatin administrationreduces organ injury and improves survival in a mouse model of polymicrobial sepsis[ J]. Immunology, 2014, 142(2): 216-226.
  • 6Zhou GX , Chao L, Chao J. Kallistatin: a novel human tissuekallikrein inhibitor. Purication, characterization, and reactive center sequence[ J]. J Biol Chem, 1992, 267(36): 25873-25880.
  • 7Lin WC, Chen CW, Huang YW, et al. Kallistatin protects against sepsisrelatedacute lung injury via inhibiting inammation and apoptosis[ J].Sci Rep, 2015, 5: 12463.
  • 8Yin H, Gao L, Shen B, et al. Kallistatin inhibits vascular inammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation[ J]. Hypertension, 2010, 56(2): 260-267.
  • 9Wang CR, Chen SY, Wu CL, et al. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation[ J]. Arthritis Rheum, 2005, 52(4):1319-1324.
  • 10Shen B, Smith RS Jr, Hsu YT, et al. Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression[ J]. J Biol Chem,2009, 284(51): 35471-35478.

二级参考文献26

  • 1Chao J, Tillman DM, Wang MY, et al. Identification of a new tissue- kallikrein-binding protein [J]. Biochem J, 1986, 239(2): 325-331.
  • 2Chao J, Miao RQ Chen V, et al. Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling[J]. Biol Chem, 2001, 382(1): 15-21.
  • 3Chen VC, Chao L, Chao J. Reactive-site specificity of human kaUistatin toward tissue kallikrein probed by site-directed mutagenesis[J]. Biochim Biophys Acta, 2000, 1479( 1-2): 237-246.
  • 4Li P, Bledsoe G, Yang ZR, et al. Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis[J]. Immunolog 2014,142(2): 216-226.
  • 5Shen 13, Hagiwara M, Yao YY, et al. Salutary effect of kaUistatin in salt- induced renal iniury, inflammation, and fibrosis via antioxidative stress[J]. Hypertension, 2008, 51 (5): 1358-1365.
  • 6Yao Y, Li L, Huang X, et al. SERPINA3K induces apoptosis in human colorectal cancer cells via activating the Fas/FasL/caspase-8 signaling pathway[J]. FEBS J, 2013, 280(14): 3244-3255.
  • 7Zhao L, Pate1 SH, Pei J, et al. Antagonizing Wnt pathway in diabetic retinopathy[J]. Diabetes, 2013, 62(12): 3993-3995.
  • 8Satoh K, Maniwa T, Oda T, et al. Proteomic profiling for the identification of serum diagnostic biomarkers for abdominal and thoracic aortic aneurysms [J]. proteome Sci, 2013, 11(1 ): 27.
  • 9Blickberg M, Berling R, Ohlsson K. Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin[J], pancreas, 1999, 19(4): 325-334.
  • 10Lin WC, Lu SL, Lin CF, et al. Plasma kaUistatin levels in patients with severe community-acquired pneumonia[J]. Crit Care, 2013, 17(1): R27.

共引文献5

同被引文献28

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部